novel strategies for several diseases including cancer progression and cystic fibrosis (8,(20)(21)(22)(23)(24). Here, we provide evidence for the first time that the inhibition of the UPS increases the stabilization of cell-cell contacts in human keratinocytes, which might be mediated by the maintenance of DP at desmosomes. Therefore, these data increase the understanding of the molecular mechanism involved in the proper localization of DP and might suggest a novel therapy approach for diseases characterized by mislocalization of DP.Acknowledgements SL designed the study, performed the research, analysed the data and wrote the paper. TMM designed the study. LBT and TMM revised the paper.This work was partially supported by DFG MA-1316/11, Bonner Forum Biomedizin and TRM Leipzig.
Conflict of interestThe authors state no conflict of interest.
References
Supporting InformationAdditional Supporting Information may be found in the online version of this article: Figure S1. Primary keratinocytes were cultured in KGM (Ctr) or in high calcium [1. Figure S2. (a) Cells were cultured in LCa or in HCa, or in the presence of ALLN [100 μM] for 3 h. Cells were stained with K5 (in green) and desmoplakin (DP; in red) antibodies. Nuclei were stained with DAPI. Arrows indicate the presence of DP at cell-cell contacts. (b) Cells were cultured in LCa or in the presence of MG132 [50lM] or in high calcium [2 mM] for 3 h. Thereafter, cells were washed with PBS and incubated with 2.4 U/ml dispase for 20 min at 37°C. Pictures were taken at indicated time-points after applying dispase. Table S1. Daegu, Korea,
793Letter to the Editor activation of signalling pathways that contribute to trichogenicity and increase the trichogenicity of cultured dermal cells. Through conduct of hair reconstitution assays, we observed that treatment of cells with FKCM resulted in induction of a greater number of hair follicles, compared with control cells. Treatment of dermal cells with FKCM resulted in the activation of BMP and b-catenin signalling pathways. In addition, higher levels of IGFBP-7, IL-8, OPG and uPA were observed in FKCM. Altogether, our data suggest that a patient's own FKCM would be ideal for expansion of the patient's own follicular dermal cells for cell therapy for treatment of hair loss.Abbreviations: DP, dermal papilla; FKCM, follicular keratinocyteconditioned media; IGFBP-7, insulin-like growth factor binding protein-7; IL-8, interleukin-8; OPG, osteoprotegerin; uPA, urokinase plasminogen activator; ORS, outer root sheath.